Northstar Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,841
Closed -$289K 167
2025
Q4
$289K Buy
+2,841
New +$228K 0.04% 139
2024
Q4
Sell
-4,321
Closed -$294K 155
2024
Q3
$294K Sell
4,321
-500
-10% -$28.2K 0.05% 125
2024
Q2
$204K Hold
4,821
0.04% 142
2024
Q1
$333K Hold
4,821
0.07% 114
2023
Q4
$357K Hold
4,821
0.08% 101
2023
Q3
$329K Sell
4,821
-200
-4% -$17K 0.08% 108
2023
Q2
$471K Sell
5,021
-150
-3% -$11.7K 0.11% 90
2023
Q1
$351K Sell
5,171
-150
-3% -$9.64K 0.09% 106
2022
Q4
$263K Buy
+5,321
New +$217K 0.07% 116
2022
Q3
Sell
-5,346
Closed -$211K 139
2022
Q2
$211K Buy
5,346
+250
+5% +$13.4K 0.06% 134
2022
Q1
$356K Sell
5,096
-161
-3% -$11.8K 0.09% 114
2021
Q4
$409K Sell
5,257
-656
-11% -$57.9K 0.1% 106
2021
Q3
$564K Sell
5,913
-570
-9% -$60.2K 0.15% 96
2021
Q2
$806K Buy
6,483
+700
+12% +$83.5K 0.21% 76
2021
Q1
$762K Buy
5,783
+393
+7% +$53.8K 0.22% 75
2020
Q4
$714K Buy
+5,390
New +$652K 0.22% 76

Other funds holding EXAS

Northstar Group's EXAS Position: Q1 2026 in Review

Northstar Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,841 shares — an estimated $289K sold.

Northstar Group first reported a position in EXAS in Q4 2020 and held it in 16 quarters. The position peaked at $806K in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Northstar Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Northstar Group sold 2,841 Exact Sciences shares in Q1 2026, an estimated $289K.
  • Northstar Group first reported a position in Exact Sciences in Q4 2020 and held it in 16 quarters.
  • Northstar Group's Exact Sciences position peaked at $806K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.